|
Workforce Development
May 15
By PBN Staff
|
Mass. biotech firms look to prepare vets for openings to comeA group of human resource executives from five Massachusetts biotechnology companies gathered Tuesday to brainstorm how to better prepare military veterans for jobs in the sector, according to the Boston Business Journal. |
|
Entrepreneurship
May 14
By PBN Staff
|
Jewelry designer, tennis online booking service, 3D printing marketplace win Business PlanThe 2013 edition of the Rhode Island Business Plan Competition announced its winners Tuesday afternoon at The Garage, the Greater Providence Chamber of Commerce’s exposition dedicated to identifying and inspiring high-growth companies in the Ocean State. |
|
Technology
May 11
|
Tech Collective accepts fellowship applicants
|
|
Biotechnology
May 1
By Anna Edney |
Amgen drugs may boost survival after a nuclear attackAmgen Inc.’s Neulasta and Neupogen and a similar blood-boosting drug from Teva Pharmaceutical Industries Ltd. may help people survive after a nuclear attack, U.S. regulators said. |
|
Biotechnology
Apr 26
By PBN Staff
|
Covidien’s profits drop in 2Q as sales rise 5%Medical technology maker Covidien Plc reported second-quarter earnings of $439 million, or 92 cents per diluted share, an 11.7 percent drop from the $497 million, or $1.02 per diluted share, it reported during the second quarter of 2012. |
|
Biotechnology
Apr 24
By Ryan Flinn |
Amgen tops analyst estimates as profit benefits from tax creditAmgen Inc., which has a production facility in West Greenwich, reported first-quarter profit that beat analyst estimates because of a research tax credit. |
|
Life Sciences
Apr 14
By Richard Asinof |
EpiVax, partners move ahead on H7N9 flu vaccine productionNew recipes for a vaccine to combat the H7N9 flu went into production this weekend, in a collaboration between EpiVax and Aldevron in Fargo, N.D., and a researcher at Fort Detrick, Md., the home of the Army Medical Research Institute of Infectious Diseases, according to Dr. Anne S. De Groot. |
